|
|
Article: NimbleGen Completes $12.5M Round For Microarray Business.(Company overview)
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
NimbleGen Systems Inc. raised $12.5 million in a Series D round of financing, bringing the total amount raised to $32.5 million, since it was founded in 1999.
NimbleGen, a spin-off of the University of Wisconsin, both of Madison, provides high-density microarray products and services to pharmaceutical companies as well as academia and government research labs, Robert Palay, CEO and chairman of NimbleGen, told BioWorld Today. The company's patented technology is called Maskless Array Synthesizer, and it provides oligonucleotide array design, manufacturing, hybridization and analysis services.
With the $12.5 million, Palay said ...